Skip to Main Content

An official website of the United States government

Explore the Early Phase Prevention Trials
Access to Data and Biospecimens

The EPPT consists of many smaller studies. Studies with data available are listed below. Click on a study to view additional information.

You may click a checkbox for a study to add it to your "Requested Studies List". Once you have selected the studies you want, you may Begin a new Project to request their data.

Study Requested? Check this box to pre-select this study's data for when you begin a new project. Organ/System Agent Participants Enrolled/Randomized Phase
MAY2012-00-01 Colorectal Linaclotide 46 / 24 I
MAY2013-01-01 Colorectal MUC1 Vaccine 130 / 120 II
MAY2016-07-01 Duodenum Erlotinib hydrochloride 46 / 46 II
MDA10-16-01 Breast DHA 84 / 65 II
MDA2013-01-01 Lung Acetylsalicylic Acid 109 / 98 II
MDA2013-01-02 Colorectal Naproxen 86 / 80 Ib
MDA2014-04-02 Breast NeuVax (nelipepimut-S + GM-CSF) 45 / 13 II
MDA2016-08-02 Breast Bexarotene Gel 41 / 24 I
NWU2013-01-03 Breast Telapristone 82 / 75 II
NWU2013-02-01 Lung Inhaled Iloprost 69 / 34 I
NWU2014-03-01 Ulcerative Colitis Berberine 20 / 18 I
NWU2015-06-04 Breast Tamoxifen 120 / 107 IIB
NWU2017-09-01 Breast Endoxifen Gel 36 / 32 I
UAZ2013-01-01 Nasal Tissue Acetylsalicylic Acid 94 / 54 II
UAZ2013-02-01 Lung Acetylsalicylic Acid and Zileuton 123 / 63 II
UAZ2014-03-01 Prostate PROSTVAC 154 / 154 II
UAZ2015-05-02 Oral Metformin 33 / 26 IIa
UAZ2017-09-02 Cigarette Smoking-Related Carcinoma Avmacol® 54 / 49 I
UWI10-16-01R Full Body 9cUAB30 - / 54 I
UWI2013-00-01 Prostate Pomegranate Extract 38 / 30 IIA
UWI2016-07-01 Oral ACTOplus Met® XR/Head and Neck 16 / 6 IIB